SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-12-043334
Filing Date
2012-08-03
Accepted
2012-08-02 19:15:41
Documents
3
Period of Report
2012-08-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CKD PRESS RELEASE rrd352039.htm 8-K 12465
2 PRESS RELEASE DATED JULY 31, 2012. rrd352039_38241.htm EX-99 4771
3 ljpcpic.jpg GRAPHIC 13881
  Complete submission text file 0001181431-12-043334.txt   37614
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 121004887
SIC: 2836 Biological Products, (No Diagnostic Substances)